Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  CytoTools AG    T5O   DE000A0KFRJ1

Real-time Quote. Real-time Tradegate - 02/24 05:36:24 pm
10.135 EUR   -1.51%
02/01 CYTOTOOLS : DermaPro_extended strategy
01/18 CYTOTOOLS : financing.pdf
2016 CYTOTOOLS : announces personnel change
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
02/17/2017 02/20/2017 02/21/2017 02/23/2017 02/24/2017 Date
10.81(c) 10.915(c) 10.775(c) 10.29(c) 10.135 Last
2 291 667 555 925 9 631 Volume
+0.75% +0.97% -1.28% -4.50% -1.51% Change
More quotes
Financials (€)
Sales 2015 1,50 M
EBIT 2015 -1,70 M
Net income 2015 -1,70 M
Finance 2015 3,30 M
Yield 2015 -
Sales 2016 -
EBIT 2016 -1,70 M
Net income 2016 -1,70 M
Finance 2016 2,30 M
Yield 2016 -
P/E ratio 2015 -
P/E ratio 2016
EV / Sales2015 11,5x
EV / Sales2016 0
Capitalization 20,6 M
More Financials
Company
CytoTools AG operates as a biotechnology company, which engages in developing therapeutic from research on programmed death cell.The company was founded by Dirk Kaiser and Mark-Andre Freyberg in 2000 and is headquartered in Darmstadt, Germany. 
More about the company
Latest news on CYTOTOOLS AG
02/16 DGAP-NEWS : CytoTools AG setzt erneut Patentschutz für DermaPro(R) durch
02/01 CYTOTOOLS : DermaPro_extended strategy
01/31 DGAP-NEWS : Eine erweiterte Strategie soll die Entwicklung der CytoTools AG erhe..
01/18 CYTOTOOLS : financing.pdf
01/12 DGAP-NEWS : Die Gesellschafter der DermaTools Biotech GmbH stellen die Weichen f..
2016 CYTOTOOLS : announces personnel change
2016 DGAP-ADHOC : Die CytoTools AG gibt eine personelle Veränderung im Vorstand bekan..
2016 CYTOTOOLS : DermaTools action for damages
2016 DGAP-NEWS : CytoTools AG: Das Tochterunternehmen DermaTools Biotech GmbH reicht ..
2016 DGAP-NEWS : Wechsel im Aufsichtsrat der CytoTools AG - Herr Dr. Tober legt aus..
More news
Sector news : Bio Therapeutic Drugs
02/22 Genmab and J&J's cancer drug set for blockbuster sales this year
02/21 Icahn buys Bristol-Myers shares, adding to activist pressure
02/21DJBristol-Myers Expands Board, Boosts Buybacks Amid Activist Pressure
02/16 How Sanofi lost out to J&J in $30 billion battle for Actelion
02/14 Gilead challenges GSK with strong HIV drug data
More sector news : Bio Therapeutic Drugs
Latest Tweets
2016CytoTools : DermaTools action for damages  
2016#Frankfurt #stocks: CytoTools : #Market Analysts conclude unsteady sales prof.. 
2016BRIEF-Cytotools unit signs contracts for production with German manufacturer ..
1
2016#Frankfurt #stocks: CytoTools : #Merger #Acquisition Analysts say: thin Feb 2.. 
2015#Frankfurt #stocks: CytoTools : #Market Analysts conclude dispiriting sales p.. 
More tweets
Qtime:2
Advertisement
Chart CYTOTOOLS AG
Duration : Period :
CytoTools AG Technical Analysis Chart | T5O | DE000A0KFRJ1 | 4-Traders
Full-screen chart
Technical analysis trends CYTOTOOLS AG
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 11,5 €
Spread / Average Target 12%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Mark-Andre Freyberg CEO & Head-Investor Relations
Manfred May Chairman-Supervisory Board
Dirk Kaiser Chief Research Officer
Markus H. Weissbach Chief Medical Officer
Dieter Tober Member-Supervisory Board
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CYTOTOOLS AG25.31%22
AMGEN, INC.18.06%128 150
CELGENE CORPORATION3.04%92 936
GILEAD SCIENCES, INC.-3.13%91 392
REGENERON PHARMACEUTIC..0.85%38 291
ACTELION LTD22.45%28 790
More Results